Literature DB >> 232607

In vitro production of steroid cataract in bovine lens. Part II: measurement of sodium-potassium adenosine triphosphatase activity.

C I Mayman, D Miller, M L Tijerina.   

Abstract

Fresh calf lesnses incubated in nutritive media containing dexamethasone phosphate or ouabain in concentrations ranging from 1 X 10(-4) M to 1 X 10(-8) M developed cortical opacification and showed significant inhibition of Na(+)-K(+) ATP'ase activity. Over a 3-day incubation period the decrease in Na+-K+ ATP'ase activity correlated well with the observed decrease in light transmission. The degree of enzyme inhibition and decrease in light transmission varied directly with the concentration of dexamethasone phosphate and ouabain, with significant changes observed at 'physiologic' and 'pharmacologic' concentrations of these agents. Lenses incubated for 4 days in dexamethasone phosphate or ouabain showed substantial increases in water content as well as an increase in Na+ and a decrease in K+ concentration. These data suggest that inhibition of the cation pump may play a significant role in the formation of steroid cataract in vitro.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 232607     DOI: 10.1111/j.1755-3768.1979.tb00545.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  3 in total

1.  Cell adhesion molecule expression in human lens epithelial cells after corticosteroid exposure.

Authors:  D Celojevic; T Carlsson; Br Johansson; U Nannmark; A Petersen
Journal:  Open Ophthalmol J       Date:  2012-06-21

Review 2.  Advances in pharmacological strategies for the prevention of cataract development.

Authors:  S K Gupta; V Kalai Selvan; S S Agrawal; Rohit Saxena
Journal:  Indian J Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.848

3.  Effects of dexamethasone on human lens epithelial cells in culture.

Authors:  A Petersen; T Carlsson; J-O Karlsson; S Jonhede; M Zetterberg
Journal:  Mol Vis       Date:  2008-07-21       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.